Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Core LaboratoriesMEX:CLB 62 Altman Z-Score is 2.96 as of Jul. 14, 2026, which is 12% below its 10-year median of 3.35. GuruFocus rates MEX:CLB with a GF Score™ of 62/100 and a GF Value™ of MXN1,344.78. The stock has 3 warning signs investors should review. Among 896 Oil & Gas companies, Core Laboratories ranks better than 66.85% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Warning Sign:
Altman Z-score of 2.84 is in the grey area. This implies that the company is under some kind of financial stress. If it is below 1.8, the company may face bankruptcy risk.
Core Laboratories has a Altman Z-Score of 2.96, indicating it is in Grey Zones. This implies that Core Laboratories is in some kind of financial stress. If it is below 1.81, the company may face bankrupcy risk.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Core Laboratories's Altman Z-Score or its related term are showing as below:
MEX:CLB'
s Altman Z-Score Range Over the Past 10 Years
Min: 1.32 Med: 3.35 Max: 10.64
Current: 2.84
During the past 13 years, Core Laboratories's highest Altman Z-Score was 10.64. The lowest was 1.32. And the median was 3.35.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Core Laboratories Altman Z-Score Related Terms
Core Laboratories Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Core Laboratories's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:CLB vs EROK, OIS, NGS: Altman Z-Score Comparison
For the Oil & Gas Equipment & Services subindustry, Core Laboratories's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Core Laboratories Altman Z-Score vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, Core Laboratories's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Core Laboratories's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Core Laboratories's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.1865
+
1.4
*
0.2917
+
3.3
*
0.0935
+
0.6
*
1.8584
+
1.0
*
0.9062
=
2.96
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Core Laboratories (MEX:CLB) has a Altman Z-Score of 2.96 as of Jul. 14, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Core Laboratories and its competitors. This is 12% below median its historical median of 3.35. Over the past decade, Core Laboratories' Altman Z-Score has ranged from 1.32 to 10.64. According to the industry distribution chart, Core Laboratories ranks #297 out of 896 companies in the Oil & Gas industry, placing it in the top 33.1%.
Is Core Laboratories' Altman Z-Score too high?
Core Laboratories' current Altman Z-Score of 2.96 is 12% below median its 10-year median of 3.35. Over the past 10 years, this metric has ranged from a low of 1.32 to a high of 10.64. The Oil & Gas industry median Altman Z-Score is 1.92. Core Laboratories' value of 2.96 is 54.6% above this industry median. Based on the distribution chart, Core Laboratories ranks #297 out of 896 companies in the Oil & Gas industry, which is above the industry midpoint. Overall, Core Laboratories has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' Altman Z-Score compare to EROK and OIS?
According to the Oil & Gas industry distribution chart, Core Laboratories ranks #297 out of 896 companies for Altman Z-Score. This puts Core Laboratories in the upper half of its industry. The industry median Altman Z-Score is 1.92. Core Laboratories' value of 2.96 is 54.6% above this benchmark. Historically, Core Laboratories' own Altman Z-Score has ranged from 1.32 to 10.64 over the past decade. While the company's 10-year median is 3.35 vs. the industry median of 1.92, Core Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for an Oil & Gas company?
The median Altman Z-Score among Oil & Gas companies is 1.92, based on 896 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Core Laboratories's current Altman Z-Score of 2.96 is 54.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Core Laboratories and its competitors. For the Oil & Gas industry, the median Altman Z-Score is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Core Laboratories's current Altman Z-Score is 2.96, which is 12% below median its own 10-year median of 3.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Core Laboratories (MEX:CLB) has a current Altman Z-Score of 2.96. The stock's GF Value™ is MXN1,344.78, compared to a current price of MXN856.38 — trading 36.3% below its estimated fair value. The current Altman Z-Score is 2.96, which is 12% below median its 10-year median of 3.35 and 54.6% above the Oil & Gas industry median of 1.92. Core Laboratories' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Core Laboratories (MEX:CLB), the current Altman Z-Score is 2.96 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Core Laboratories (MEX:CLB) Overvalued in 2026?
Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued.
The current stock price of MXN856.38 is trading 36.3% below its estimated GF Value™ of MXN1,344.78.
Key valuation signals for MEX:CLB:
Altman Z-Score: 2.96 (12% below median its 10-year median of 3.35)
GF Value™: MXN1,344.78 vs. price of MXN856.38 (36.3% below fair value)
Industry Position: 54.6% above the Oil & Gas median (#297 of 896)
No single metric tells the full story. See the MEX:CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
62GF Score
Get the complete analysis for MEX:CLB
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CLB has been successfully added to your 
